（记者 曾健辉） 每经头条（nbdtoutiao）——已有75人遇难，1名死者为消防员，还有10名消防员受伤！记者现场直击香 港大埔火灾：燃烧的宏福苑，五级大火的五个谜团 2025年1至6月份，沃森生物的营业收入构成为：自主疫苗占比94.82%，中间产品收入占比4.67%，其他 业务占比0.26%，服务收入占比0.24%。 截至发稿，沃森生物市值为194亿元。 每经AI快讯，沃森生物（SZ 300142，收盘价：12.16元）11月28日晚间发布公告称，公司第五届第三十 三次董事会会议于2025年11月28日以通讯表决的方式召开。会议审议了《关于聘请公司2025年度审计机 构的议案》等文件。 ...

Core Viewpoint - Watson Bio announced a government subsidy of 89 million yuan, which significantly impacts its financials, particularly its net profit and net assets [1] Group 1: Government Subsidy - Watson Bio's subsidiary received a government subsidy of 89 million yuan on October 29, 2025 [1] - The subsidy includes 56.58 million yuan related to income, accounting for 39.8% of the company's audited net profit attributable to shareholders for the most recent fiscal year [1] - An additional 32.42 million yuan is related to assets, representing 0.34% of the company's audited net assets for the same period [1] Group 2: Revenue Composition - For the first half of 2025, Watson Bio's revenue composition was as follows: 94.82% from self-developed vaccines, 4.67% from intermediate products, 0.26% from other businesses, and 0.24% from service income [1] Group 3: Market Capitalization - As of the report, Watson Bio's market capitalization stands at 18.8 billion yuan [1]